EUDA Declares Reverse Stock Split of Its Ordinary Shares

(SeaPRwire) –   SINGAPORE, March 19, 2026 — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based provider of non-invasive healthcare services in Asia, with operations in Singapore, Malaysia, and China, today announced its intention to execute a reverse stock split of its ordinary shares at a ratio of 1-for-20 (the “Reverse Stock Split”). This action has received approval from the Company’s Board of Directors, in accordance with the laws of the British Virgin Islands. The Reverse Stock Split is scheduled to become effective at the market open on March 23, 2026. Following this, the ordinary shares will continue to trade on the Nasdaq Capital Market under the Company’s existing ticker symbol “EUDA” on a post-split basis. The new CUSIP number for EUDA’s ordinary shares after the Reverse Stock Split will be G3142E147.

Upon the effectiveness of the Reverse Stock Split, the total number of ordinary shares held by each stockholder will be automatically adjusted. The new number of shares will be calculated by dividing the number of issued and outstanding ordinary shares held by each stockholder immediately before the Reverse Stock Split by twenty (20). Any resulting fractional shares will be rounded up to the nearest whole share. Consequently, no fractional shares will be issued, and no cash or other compensation will be provided for any fractional shares that might otherwise arise from the Reverse Stock Split.

The Company currently has approximately 50,307,491 ordinary shares outstanding. Post-Reverse Stock Split, the Company anticipates having approximately 2,515,375 ordinary shares outstanding. Each stockholder’s percentage ownership in the Company and their proportionate voting power will remain consistent, with only minor adjustments due to the handling of fractional shares. The rights and privileges associated with holding ordinary shares will remain largely unchanged by the Reverse Stock Split.

In conjunction with the Reverse Stock Split, the terms of the Company’s warrants will be adjusted proportionally. This means the number of ordinary shares underlying the warrants will be reduced, and the exercise price of the warrants will be increased. Currently, an aggregate of 8,917,250 warrants are outstanding, allowing for the issuance of approximately 4,458,625 ordinary shares upon exercise, with each warrant having an exercise price of $11.50 per share. Following the Reverse Stock Split, approximately 222,932 ordinary shares would be issuable upon the exercise of the same 8,917,250 warrants, with each warrant now entitling the holder to purchase one-fortieth of one ordinary share at an exercise price of $230.00 per share.

The consolidation and reduction of ordinary shares resulting from the Reverse Stock Split will occur automatically at the effective time without requiring any further action from the Company’s stockholders. Equiniti, the Company’s transfer agent, will serve as the exchange agent for the Reverse Stock Split. Stockholders of record who hold their shares in book-entry form will receive a transaction notice from the transfer agent detailing the number of common shares held after the Reverse Stock Split. Stockholders whose shares are held through a broker, bank, or other nominee will have their positions adjusted to reflect the Reverse Stock Split, subject to the nominee’s specific procedures, and are not expected to need to take any action. Holders of physical stock certificates are encouraged, but not required, to send their certificates to the Company’s transfer agent, which will then issue a new stock certificate reflecting the Reverse Stock Split to those who request it.

About EUDA Health Holdings Limited

EUDA Health Holdings Limited (NASDAQ: EUDA) is a prominent Singapore-based non-invasive healthcare provider in Asia, focusing its services on Singapore, Malaysia, and China. The Company is committed to becoming a leader in non-invasive and preventive healthcare, with a strategic emphasis on the rapidly expanding longevity sector. Its mission is to address the evolving healthcare needs of over 1.8 billion individuals across the region, which is experiencing significant demographic shifts with over 30% of its population aging rapidly. By delivering innovative, accessible, and scientifically validated health solutions, EUDA is positioned to spearhead the transformation of regional healthcare from a reactive medical treatment model to a proactive, longevity-focused approach. EUDA also operates a property management business based in Singapore.

Forward-Looking Statements

This document may contain forward-looking statements that involve risks and uncertainties. These statements are often identified by words such as “estimates,” “projected,” “expects,” “envisions,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose,” and variations of these or similar expressions, or their negative counterparts. These forward-looking statements do not guarantee future performance, conditions, or results and are subject to numerous known and unknown risks, uncertainties, assumptions, and other important factors, many of which are beyond EUDA’s control. These factors could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Readers should not place undue reliance on forward-looking statements, which are applicable only as of the date of this document. The Company undertakes no obligation to update or revise any forward-looking statements, whether due to new information, future events, or otherwise, except as required by law.

Christensen Advisory

Christian Arnell
Phone: +852 2117 0861
Email: christian.arnell@christensencomms.com